BioNexus Gene Lab Corp. Accounts Receivable, Held-for-Sale, Not Part of Disposal Group, after Valuation Allowance
BioNexus Gene Lab Corp. (BGLC) had Accounts Receivable, Held-for-Sale, Not Part of Disposal Group, after Valuation Allowance of $2.19 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › and Others
us-gaap:TradeReceivablesHeldForSaleNetNotPartOfDisposalGroup · last filed 2025-11-14
- 2025-09-30: Accounts Receivable, Held-for-Sale, Not Part of Disposal Group, after Valuation Allowance $2.19M.
- 2025-06-30: Accounts Receivable, Held-for-Sale, Not Part of Disposal Group, after Valuation Allowance $2.35M.
- 2025-03-31: Accounts Receivable, Held-for-Sale, Not Part of Disposal Group, after Valuation Allowance $1.98M.
- 2024-12-31: Accounts Receivable, Held-for-Sale, Not Part of Disposal Group, after Valuation Allowance $1.89M.
| Period end | Accounts Receivable, Held-for-Sale, Not Part of Disposal Group, after Valuation Allowance |
|---|---|
| 2025-09-30 | $2.19M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.35M 10-Q · filed 2025-08-18 |
| 2025-03-31 | $1.98M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.89M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $2.07M 10-Q · filed 2024-11-15 |
| 2024-06-30 | $1.79M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.18M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.11M 10-K · filed 2025-04-15 |
| 2023-09-30 | $2.22M 10-Q/A · filed 2024-03-26 |
| 2023-06-30 | $2.49M 10-Q · filed 2023-08-16 |
| 2022-12-31 | $2.87M 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |